GeneDx Holdings Corp. WGS
Updated: 11 Aug 2026
No signal published yet
We already track GeneDx Holdings and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.
Email when we publish a signal or something material happens · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more
Temporary check — not Firelda's published signal.
General analysis — not personal advice.
Want to follow GeneDx Holdings Corp.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.
Follow GeneDx Holdings free Follow freeEmail when we publish a signal or something material happens · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more
Recent News
On August 3, 2026, GeneDx reported its second quarter 2026 financial results, with revenue rising 11% year-over-year to $114.4 million and exome and genome test volumes growing 32%. The company achieved a 70% adjusted gross margin and returned to profitability on an adjusted net income basis of $0.4 million. In conjunction with the earnings release, GeneDx expanded its loan facility with Blackstone by $50 million and reaffirmed its full-year 2026 revenue guidance.
What Firelda Watch includes for GeneDx Holdings Corp.
Add the company to your watchlist and get all of this automatically.
- Free: 3 companies on your watchlist
- Change history and monitoring for every company you follow
- Sunday weekly brief — a short weekly roundup
- Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
Want to follow GeneDx Holdings Corp.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.
Follow GeneDx Holdings free Follow freeEmail when we publish a signal or something material happens · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more